It’s harder than ever for healthcare messaging to have an impact on target audiences. Find out what it takes for your brand to cut through the noise and make a connection.
Soon enough, COVID-19 will be the stuff of blockbusters and bestsellers, full of cliffhangers and drama. Now, it's worth taking a moment to applaud the superhuman accomplishments of vaccine scientists worldwide.
COVID-19 has forced the pharma industry to pivot, and we’ve learned a lot about ourselves and our audiences. Our latest whitepaper features new insights, practical solutions and proven tactics to implement now to evolve your commercial strategy.
Med Ad News recently released its annual healthcare agency roundtable edition, which features a Q&A with leadership of the 2020 Manny Award winners. Six Intouch execs shared their thoughts on industry trends and what they expect to see in 2021.
Each year, Intouch creates a “what to watch for” POV to help pharma marketers prepare for the coming year. Here, we explore 5 interrelated aspects of the pandemic’s effects, predict how they will continue to play out in 2021, and recommend how to grow and benefit from them.
From increasing diversity in clinical trials, to making the most of patient interviews, to what comes next for pharma in 2021, we've got key takeaways from the Re:Imagine Pharma Marketing conference.
For years, third-party tracking cookies were the backbone of the internet. Now, marketers must develop strategies to address targeting and measurement in a world without them. Read on to get creative solutions that keep messaging personalized in a cookieless world.
Getting patients in front of HCPs for diagnosis, treatment, and care management continues to be challenging. Here, we look at three campaigns' efforts to help patients understand why, and how, to continue getting the care that they need.
Get a sneak peek at our soon-to-be-released whitepaper, “The Now and the Next in Pharma Marketing: Research and Insights to Innovate in a New Normal" at the virtual Re:Imagine Pharma Marketing conference!
The presidential election is around the corner, and several key issues are in play, regardless of who wins. From drug pricing to DTC to disparities in healthcare and more, we drill down to what matters for pharma.
